Oxana Beskrovnaya - Chief Scientific Officer, Dyne Therapeutics, Inc

As of June 15, 2022


What is Oxana Beskrovnaya's Net Worth?

The current estimated net worth of Dyne Therapeutics, Inc's Chief Scientific Officer, Oxana Beskrovnaya, is estimated to be about $117.54K . Oxana Beskrovnaya owns about 53,676 units of Dyne Therapeutics, Inc common stock. In the last 2 years at Dyne Therapeutics, Inc, Oxana Beskrovnaya has sold an estimated value of $32.6K worth.

What is Oxana Beskrovnaya's Past Insider Trading?

Oxana Beskrovnaya's largest sale order was 1,444 units , worth over $22.95K on September 22, 2021. In total, Oxana Beskrovnaya has made about 6 transactions over 2 years of their time at Dyne Therapeutics, Inc. Oxana Beskrovnaya usually trades in September and June, with the busiest year in 2021. The most recent transaction was a sale order of 693 units , worth over $6.05K on March 14, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Oxana Beskrovnaya's' Mailing Address?

  • Mailing address is C/o Dyne Therapeutics, Inc. 830 Winter Street Waltham MA 02451 MA

Dyne Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Joshua Brumm 2020 $482,667 - $3,134,366 $7,944,295 $299,877 $6,900 $11,868,105
Joshua Brumm 2019 $97,212 $180,000 - - - $102 $277,314
Romesh Subramanian, Ph.D. 2020 $371,875 - $987,285 $2,818,520 $186,395 $6,900 $4,370,975
Romesh Subramanian, Ph.D. 2019 $350,002 - - - $61,250 $408 $411,660
Susanna High 2020 $167,778 - $858,106 $2,646,267 $73,336 $418 $3,745,905
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1818794/000119312521116286/d937458ddef14a.htm

What are Dyne Therapeutics, Inc's Past Insider Trades?

Dyne Therapeutics, Inc's most recent insider trade came on March 14, 2022 by Richard Scalzo who sold 308 units worth $2.69K . In the last 15 years, insiders at Dyne Therapeutics, Inc have sold an estimated value of $1.64B and bought an estimated value of $43.97M worth of shares. Insider trading is most common in March, with the busiest year in 2015. The most active traders at the company are Franklin Resources Inc,  Robert Flexon, President and CEO,  and Catherine James, EVP and General Counsel .

Dyne Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1